Abstract
Background: Alzheimer's disease (AD) is a typical neurodegenerative disease with a complex etiology. Until now, there has been no effective treatment available for AD; however, improving energy dysmetabolism, the key pathological event in the early stage of AD, can effectively delay the progression of AD.
Objective: This paper aims to investigate the therapeutic effect and potential mechanism of the new Tiaoxin recipe on early AD.
Methods: APP/PS1 mice were divided into a model group, a new Tiaoxin recipe group, and a donepezil group, and C57/BL mice were used for the control group. Mouse cognitive and learning abilities were tested using the Morris water maze test and a new object-recognition experiment. The 42 amino acid form of amyloid β peptide (Aβ1–42) content was detected by enzyme-linked immunosorbent assay, the senile plaque area was detected by thioflavin S staining, and the senescence- associated β-galactosidase (SA-β-gal)–positive area was detected by chemical staining. Also, the adenosine triphosphate (ATP), nicotinamide adenine dinucleotide (NAD+), and nicotinamide adenine dinucleotide hydride (NADH) contents were detected using a biochemical method, and the cluster of differentiation 38 (CD38) and silent mating–type information regulation 2 homolog 3 (SIRT3) protein expression levels were detected by immunofluorescence and Western blot analysis.
Results: Compared with those of the control group, the learning and memory abilities of the model group were impaired; the senile plaque deposition, Aβ1–42 content, and SA-βgal–positive staining area were increased; the ATP concentration, NAD+ concentration, and NAD+/NADH ratio were decreased; the CD38 protein expression level was increased; and the SIRT3 protein expression level was decreased. Following intervention with the new Tiaoxin recipe, the learning and memory abilities were improved; the senile plaque deposition, Aβ1–42 content, and SA-βgal–positive area were reduced; the ATP concentration, NAD+ concentration, and NAD+/NADH ratio were increased; CD38 protein expression was decreased, and SIRT3 protein expression was increased.
Conclusion: This study shows that the new Tiaoxin Recipe can improve cognitive ability and reduce the Aβ1-42 content and senile plaque deposition in APP/PS1 mice, which may occur through the downregulation of CD38 protein expression, upregulation of SIRT3 protein expression, restoration of the NAD+ level, promotion of ATP synthesis, mitigation of energy metabolism disorders.
Graphical Abstract
[http://dx.doi.org/10.1038/d41586-017-08668-6]
[http://dx.doi.org/10.5114/fn.2019.85929] [PMID: 31556570]
[PMID: 24434253]
[http://dx.doi.org/10.1038/s41573-020-0072-x] [PMID: 32709961]
[http://dx.doi.org/10.1016/j.freeradbiomed.2016.04.200] [PMID: 27154981]
[http://dx.doi.org/10.1038/s41392-020-00311-7] [PMID: 33028824]
[http://dx.doi.org/10.3109/10409238.2015.1028612] [PMID: 25837229]
[http://dx.doi.org/10.1016/j.cmet.2018.02.011] [PMID: 29514064]
[http://dx.doi.org/10.15252/embj.201797135] [PMID: 28784597]
[http://dx.doi.org/10.1002/pro.2859] [PMID: 26660500]
[http://dx.doi.org/10.1002/ana.24425] [PMID: 25893674]
[http://dx.doi.org/10.16306/j.1008-861x.2003.03.012]
[http://dx.doi.org/10.1007/s00018-014-1634-z] [PMID: 24803005]
[http://dx.doi.org/10.1242/jcs.113.20.3613] [PMID: 11017877]
[http://dx.doi.org/10.1016/j.nicl.2018.01.031] [PMID: 29876246]
[http://dx.doi.org/10.1089/ars.2017.7269] [PMID: 29634344]
[http://dx.doi.org/10.3390/cells7120235] [PMID: 30487434]
[http://dx.doi.org/10.3233/JAD-170585] [PMID: 29036828]
[http://dx.doi.org/10.3390/nu11030504] [PMID: 30818813]
[http://dx.doi.org/10.1038/s41586-018-0645-6] [PMID: 30356218]
[http://dx.doi.org/10.1073/pnas.1718819115] [PMID: 29432159]
[http://dx.doi.org/10.1126/science.abi6401] [PMID: 34353940]
[PMID: 22375410]
[http://dx.doi.org/10.1016/S0378-8741(02)00290-8] [PMID: 12499082]
[http://dx.doi.org/10.1089/acm.2006.6107] [PMID: 17480132]
[http://dx.doi.org/10.3390/ijms18122746] [PMID: 29258283]
[http://dx.doi.org/10.18632/aging.103131] [PMID: 32352928]
[http://dx.doi.org/10.3892/br.2020.1344] [PMID: 32874571]
[http://dx.doi.org/10.1109/TNB.2021.3075733] [PMID: 33900920]
[http://dx.doi.org/10.1016/j.jpdc.2022.03.011]
[http://dx.doi.org/10.1109/TNB.2021.3130811] [PMID: 34822331]
[http://dx.doi.org/10.1109/TNB.2021.3065051] [PMID: 33690123]